A Comparison of Tracheal Intubation Using the Totaltrack vs the Airtraq Laryngoscope in Routine Airway Management

October 13, 2016 updated by: Manuel Ángel Gómez-Ríos
Endotracheal intubation is usually required to allow unrestricted surgical approach. The Macintosh laryngoscope is the standard method. However in certain situations as difficult airway this technique is ineffective and poorly tolerated by the patient. Fiberoptic intubation is the gold standard in this scenario, however sometimes it is not possible due to failure or unavailability, so alternatives are needed. The TotalTrack (MedComflow SA, Barcelona, Spain) and the Airtraq (Prodol Meditec, Vizcaya, España) been designed specifically for the airway management. However, despite their use in clinical practice, there are no comparative studies.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

48

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • A Coruña, Spain, 15006
        • Recruiting
        • Manuel Gómez Ríos
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients undergoing elective general anesthesia requiring OTI.
  • Patients duly informed and they have signed the informed consent during the pre-anesthetic consultation, or be sought after due meditation, expressing its consent to the inclusion in the study.
  • Age ≥18 years.
  • ASA I-III.
  • Sufficient intellectual capacity to understand the procedure and equipment used.
  • Do not submit predictors of difficult airway (Mallampati class III or IV; thyromental distance <6 cm, sternomental distance <12.5 cm, interincisal distance<4.0 cm, bite test II or III, cervical mobility <90 ° or history of difficult intubation).
  • Do not undergo thyroid surgery or present pharyngolaryngeal, glottic or cervical pathology
  • BMI <30kg / m2
  • Not presenting risk factors for aspiration
  • Not presenting respiratory disease, coronary or cerebral vascular.
  • Do not have a sore throat preoperative

Exclusion Criteria:

  • Failure to meet the above criteria
  • Pregnancy
  • Allergy to any drug included in the protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Airtraq
OTI with Airtraq
Active Comparator: Totaltrack
OTI with TotalTrack

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Total time of successful intubation
Time Frame: Time of Orotracheal intubation (TOTI)
Time of Orotracheal intubation (TOTI)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentage of glottic opening (POGO Score)
Time Frame: TOTI
TOTI
number of maneuvers
Time Frame: TOTI
TOTI
Number of attempts of endotracheal intubation
Time Frame: TOTI
TOTI
Position taken by the anesthesiologist during orotracheal intubation
Time Frame: TOTI
TOTI
Complications
Time Frame: OTI and postintubation (24 hours)
OTI and postintubation (24 hours)
endotracheal intubation success rate of each device
Time Frame: TOTI
TOTI
Degree of satisfaction
Time Frame: time of postintubation (ten minutes)
Visual Analogic Scale
time of postintubation (ten minutes)
difficulty in intubation (IDS scale)
Time Frame: TOTI
TOTI
hemodinamic response
Time Frame: OTI pre and postintubation (time minutes)
heart ratio, arterial pressure
OTI pre and postintubation (time minutes)
hemodinamic response
Time Frame: OTI pre and postintubation (time minutes)
arterial pressure
OTI pre and postintubation (time minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2016

Primary Completion (Anticipated)

November 1, 2017

Study Registration Dates

First Submitted

March 10, 2015

First Submitted That Met QC Criteria

March 17, 2015

First Posted (Estimate)

March 23, 2015

Study Record Updates

Last Update Posted (Estimate)

October 17, 2016

Last Update Submitted That Met QC Criteria

October 13, 2016

Last Verified

October 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • MGR-TAT-2015-F1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endotracheal Intubation

Clinical Trials on Orotracheal intubation with Totaltrack

3
Subscribe